Antigen presentation by macrophages harboring intravesicular pathogens

Parasitology Today

Volumn 15, Issue 8, 1999, Pages 325-332

  Overath, Peter ^a   Aebischer, Toni ^a  

^a MAX PLANCK INST FÜR BIOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL VACCINE;

ANTIGEN PRESENTATION; CELL ACTIVATION; ENDOSOME; HOST CELL; LEISHMANIASIS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PARASITE; PROTOZOON; REVIEW; T LYMPHOCYTE;

PROTOZOA;

EID: 0033178708     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01473-8     Document Type: Review

References (61)

1. Mellman I.et al. Antigen processing for amateurs and professionals. Trends Cell Biol. 8:1998;231-237.
2. Reiner S.L.et al. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
3. Aebischer T.et al. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:1993;220-226.
4. Satoskar A.et al. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 63:1995;4894-4899.
5. Wang Z.E.et al. Targeted activation of CD8 cells and infection of β2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 151:1993;2077-2086.
6. Overath P., Harbecke D. Course of Leishmania infection in β2-microglobulin-deficient mice. Immunol. Lett. 37:1993;13-17.
7. Moll H.et al. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1993;1595-1601.
8. Blank C.et al. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J. Infect. Dis. 167:1993;418-425.
9. Cella M.et al. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:1997;782-787.
10. Pierre P.et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:1997;787-792.
11. Valitutti S.et al. Serial triggering of many T cell receptors by few peptide-MHC complexes. Nature. 375:1995;148-151.
12. Antoine J.C.et al. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect. Immun. 59:1991;764-775.
13. Fruth U.et al. Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150:1993;1857-1864.
14. Wolfram M.et al. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. Eur. J. Immunol. 25:1995;1094-1100.
15. Bogdan C.et al. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1990;1131-1135.
16. Liew F.Y.et al. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:1990;4306-4310.
17. Russell D.G.et al. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J. Cell Sci. 103:1992;1193-1210.
18. Antoine J.C.et al. The biogenesis and properties of the parasitophorous vacuoles that harbor Leishmania in murine macrophages. Trends Microbiol. 7:1998;392-401.
19. De Souza L.et al. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108:1995;3219-3231.
20. Shepherd V.L.et al. Receptor-mediated entry of β-glucuronidase into the parasitophorous vacuoles of macrophages infected with Leishmania mexicana amazonensis. J. Exp. Med. 157:1983;1471-1482.
21. Wolfram M.et al. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface. Eur. J. Immunol. 26:1996;3153-3162.
22. Reiner N.E.et al. Parasite accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol. 138:1987;1926-1932.
23. Kaye P.M.et al. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24:1994;2850-2854.
24. Prina E.et al. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J. Immunol. 151:1993;2050-2061.
25. Rabinovitch M.et al. Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters. J. Exp. Med. 163:1986;520-535.
26. Prina E.et al. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J. Immunol. 156:1996;4318-4327.
27. Winter G.et al. Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid. J. Cell Sci. 107:1994;2471-2482.
28. McConville M.J., Blackwell J.M. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266:1991;15170-15179.
29. Medina-Acosta E.et al. The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol. Biochem. Parasitol. 37:1989;263-273.
30. Bahr V.et al. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana. Mol. Biochem. Parasitol. 58:1993;107-121.
31. Ilg T.et al. The lysosomal gp63-related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimum. FEBS Lett. 327:1993;103-107.
32. + T cells. Eur. J. Immunol. 26:1996;3163-3169.
33. Handman E.et al. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect. Immun. 63:1995;4261-4267.
34. Soong L.et al. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63:1995;3559-3566.
35. Rangarajan D.et al. The gene B protein localises to the surface of Leishmania major parasites in the absence of metacyclic stage lipophosphoglycan. J. Cell Sci. 108:1995;3359-3366.
36. Jardim A.et al. Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein. Biochem. J. 305:1995;307-313.
37. Ilg T.et al. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes. Eur. J. Cell Biol. 66:1995;205-215.
38. Ilg T.et al. Stage-specific proteophosphoglycan from Leishmania mexicana amastigotes. J. Biol. Chem. 273:1998;13509-13523.
39. Russell D.G., Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1988;1274-1279.
40. McMahon-Pratt D.et al. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infect. Immun. 61:1993;3351-3359.
41. Mougneau E.et al. Expression cloning of a protective Leishmania antigen. Science. 268:1995;563-566.
42. Reiner S.L.et al. Control of Leishmania major by a monoclonal α,β T cell repertoire. J. Immunol. 160:1998;884-889.
43. Stenger S.et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1996;1501-1514.
44. Kaufmann S.H.E. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:1993;129-163.
45. Clemens D.L. Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol. 4:1996;113-118.
46. Russell D.G.et al. Why intracellular parasitism need not be a degrading experience for Mycobacteria. Philos. Trans. R. Soc. London Ser. B. 352:1997;1303-1310.
47. Clemens D.L.et al. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:1995;257-270.
48. Schaible U.E.et al. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160:1998;1290-1296.
49. + T cells of mycobacteria growing in human macrophages. Science. 260:1993;984-986.
50. Gercken J.et al. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62:1994;3472-3478.
51. VanHeyningen T.K.et al. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J. Immunol. 158:1997;330-337.
52. Kaufmann S.H., Andersen P. Liew F.Y., Cox F.E.G. Immunology of Intracellular Parasitism. 1998;21-59 Karger, Basel.
53. Clemens D.L.et al. Membrane sorting during phagocytosis: selective exclusion of major histocompatibility complex molecules but not complement receptor CR3 during conventional and coiling phagocytosis. J. Exp. Med. 175:1992;1317-1326.
54. Clemens D.L.et al. Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes. Infect. Immun. 61:1993;2803-2812.
55. Blander S.J.et al. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J. Exp. Med. 169:1989;691-705.
56. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175:1992;1531-1538.
57. Harty J.T., Pamer E.G. CD8 lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J. Immunol. 154:1995;4642-4650.
58. Shen H.et al. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell. 92:1998;535-545.
59. Hess J.et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1458-1463.
60. Sijts A.J.et al. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156:1996;683-692.
61. Vijh S.et al. Effect of antigen-processing on in vivo T cell response magnitudes. J. Immunol. 160:1998;3971-3977.